Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY)

This study has been completed.
Information provided by (Responsible Party):
Celsion Identifier:
First received: January 19, 2009
Last updated: September 1, 2016
Last verified: September 2016